{"id":17360,"date":"2026-08-12T01:01:53","date_gmt":"2026-08-12T01:01:53","guid":{"rendered":"https:\/\/pharmamachinecn.com\/?p=17360"},"modified":"2026-05-11T08:20:59","modified_gmt":"2026-05-11T08:20:59","slug":"what-is-regulatory-compliance-in-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/pharmamachinecn.com\/tr\/what-is-regulatory-compliance-in-pharmaceutical-industry\/","title":{"rendered":"\u0130la\u00e7 Sekt\u00f6r\u00fcnde Mevzuata Uyum Nedir?"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"17360\" class=\"elementor elementor-17360\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-656075b4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"656075b4\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-78348194\" data-id=\"78348194\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2b902b66 product-data-tab elementor-widget elementor-widget-text-editor\" data-id=\"2b902b66\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>\u0130la\u00e7 end\u00fcstrisinde mevzuata uygunluk, ila\u00e7lar\u0131n geli\u015ftirilmesi, \u00fcretilmesi, test edilmesi, depolanmas\u0131 ve da\u011f\u0131t\u0131m\u0131na ili\u015fkin kurallara uymak anlam\u0131na gelir. Bu kurallar d\u00fczenleyici makamlar taraf\u0131ndan belirlenir ve bir \u00fcr\u00fcn\u00fcn ya\u015fam d\u00f6ng\u00fcs\u00fcn\u00fcn her a\u015famas\u0131nda ge\u00e7erlidir.<\/p><figure id=\"attachment_17434\" aria-describedby=\"caption-attachment-17434\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-full wp-image-17434\" src=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry.jpg\" alt=\"\u0130la\u00e7 Sekt\u00f6r\u00fcnde Mevzuata Uyum\" width=\"1000\" height=\"618\" title=\"\" srcset=\"https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry.jpg 1000w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry-500x309.jpg 500w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry-300x185.jpg 300w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry-768x475.jpg 768w, https:\/\/pharmamachinecn.com\/wp-content\/uploads\/2026\/08\/Regulatory-Compliance-in-Pharmaceutical-Industry-18x12.jpg 18w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><figcaption id=\"caption-attachment-17434\" class=\"wp-caption-text\"><em><strong>\u0130la\u00e7 Sekt\u00f6r\u00fcnde Mevzuata Uyum.<\/strong><\/em><\/figcaption><\/figure><p>Uygulamada, mevzuata uygunluk, kay\u0131tlar\u0131n do\u011fru tutulmas\u0131n\u0131 sa\u011flayan do\u011fru s\u00fcre\u00e7lerin y\u00fcr\u00fcrl\u00fckte olmas\u0131 anlam\u0131na gelir; b\u00f6ylece \u00fcr\u00fcnlerin standartlara uygun oldu\u011funu d\u00fczenleyici kurumlara kan\u0131tlayabilirsiniz.<\/p><p>A\u015fa\u011f\u0131da, ila\u00e7 sekt\u00f6r\u00fcnde mevzuata uyumun ne anlama geldi\u011fini, bunun temel gerekliliklerini ve ba\u015fl\u0131ca d\u00fczenleyici kurumlar\u0131 ayr\u0131nt\u0131l\u0131 olarak ele alaca\u011f\u0131z. Hadi ayr\u0131nt\u0131lara ge\u00e7elim!<\/p><h2><strong><b>\u0130la\u00e7 Sekt\u00f6r\u00fcnde Mevzuata Uyum Nedir?<\/b><\/strong><\/h2><p>Mevzuata uygunluk, geli\u015ftirme a\u015famas\u0131ndan sat\u0131\u015fa kadar her s\u00fcreci d\u00fczenleyen yasalar, k\u0131lavuzlar ve standartlara uymak anlam\u0131na gelir. Bu kurallar, ila\u00e7lar\u0131n g\u00fcvenli olmas\u0131n\u0131 ve her seferinde ayn\u0131 \u015fekilde \u00fcretilmesini sa\u011flamak amac\u0131yla FDA gibi sa\u011fl\u0131k otoriteleri taraf\u0131ndan belirlenir.<\/p><p>G\u00fcnl\u00fck i\u015f ak\u0131\u015f\u0131nda uyum, onaylanm\u0131\u015f prosed\u00fcrlerin uygulanmas\u0131n\u0131, do\u011fru kay\u0131tlar\u0131n tutulmas\u0131n\u0131 ve denetimlere uygun \u015fekilde yan\u0131t verilmesini i\u00e7erir.<\/p><p>Basit\u00e7e ifade etmek gerekirse, bu, operasyonlar\u0131n, kalite sistemlerinin ve kararlar\u0131n nas\u0131l y\u00f6netildi\u011fini belirleyen, s\u00fcrekli bir sorumluluktur.<\/p><h2><strong><b>Alt\u0131 \u00d6nemli D\u00fczenleyici \u00c7er\u00e7eve ve Standart<\/b><\/strong><\/h2><p>\u0130\u015fte \u015firketlerin mevzuata uygun hareket etmelerine yard\u0131mc\u0131 olan en \u00f6nemli alt\u0131 d\u00fczenleyici \u00e7er\u00e7eve ve standart:<\/p><h3><strong><b>1. \u0130yi \u00dcretim Uygulamalar\u0131 (GMP)<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/gmp-for-pharmaceutical-manufacturing\/\"><u>GMP standartlar\u0131<\/u><\/a>\u00a0\u0130la\u00e7lar\u0131n tutarl\u0131 kalitesini garanti alt\u0131na almak i\u00e7in nas\u0131l \u00fcretilmesi gerekti\u011fini belirler. Bu standartlar, kontroll\u00fc s\u00fcre\u00e7lere, e\u011fitimli personele, temiz tesislere ve uygun belgelemeye odaklan\u0131r. Bu standartlar, \u015firketlerin onaylanm\u0131\u015f prosed\u00fcrlere uymas\u0131n\u0131 gerektirir.<\/p><p>Denetimler s\u0131ras\u0131nda, d\u00fczenleyici kurumlar sadece prosed\u00fcrlerde yaz\u0131lanlara de\u011fil, GMP\u2019nin g\u00fcnl\u00fck faaliyetlerde nas\u0131l uyguland\u0131\u011f\u0131na da yak\u0131ndan bakarlar. GMP sistemleri zay\u0131fsa, \u00fcr\u00fcn kalitesi ve hasta g\u00fcvenli\u011fi tehlikeye girer.<\/p><h3><strong><b>2. GxP (\u0130yi Uygulama) Gereklilikleri<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/gxp-in-pharmaceutical-industry-a-complete-compliance-guide\/\"><u>GxP (\u0130yi Uygulama)<\/u><\/a>\u00a0a\u015fa\u011f\u0131dakileri kapsayan genel bir terimdir:<\/p><ul><li><b><\/b><strong><b>GCP (\u0130yi Klinik Uygulamalar)<\/b><\/strong>: Klinik ara\u015ft\u0131rmalar i\u00e7in ge\u00e7erlidir ve hasta g\u00fcvenli\u011fini ve veri b\u00fct\u00fcnl\u00fc\u011f\u00fcn\u00fc korur.<\/li><li><b><\/b><strong><b>GLP (\u0130yi Laboratuvar Uygulamalar\u0131)<\/b><\/strong>: Laboratuvar \u00e7al\u0131\u015fmalar\u0131n\u0131 denetler ve test sonu\u00e7lar\u0131n\u0131n g\u00fcvenilir olmas\u0131n\u0131 sa\u011flar.<\/li><li><b><\/b><strong><b>GSY\u0130H (Do\u011fru Da\u011f\u0131t\u0131m Uygulamalar\u0131)<\/b><\/strong>: Depolama, nakliye ve tedarik zinciri s\u00fcre\u00e7leri s\u0131ras\u0131nda \u00fcr\u00fcn kalitesinin korunmas\u0131na odaklan\u0131r.<\/li><\/ul><p>Bu gereklilikler, her a\u015faman\u0131n belirlenen standartlara uygun olarak y\u00fcr\u00fct\u00fclmesi, do\u011fru verilerin kullan\u0131lmas\u0131 ve denetimler s\u0131ras\u0131nda do\u011frulanabilmesi i\u00e7in getirilmi\u015ftir.<\/p><h3><strong><b>3. ICH K\u0131lavuzlar\u0131<\/b><\/strong><\/h3><p>Uluslararas\u0131 Uyum Konseyi (ICH), farkl\u0131 b\u00f6lgelerdeki d\u00fczenleyici beklentileri birbiriyle uyumlu hale getirmek amac\u0131yla k\u00fcresel k\u0131lavuzlar haz\u0131rlamaktad\u0131r. Bu k\u0131lavuzlar, kalite, g\u00fcvenlik ve etkinlik gerekliliklerini kapsamaktad\u0131r.<\/p><p>\u00d6rnekler aras\u0131nda \u015funlar say\u0131labilir: <a href=\"https:\/\/database.ich.org\/sites\/default\/files\/Q8%28R2%29%20Guideline.pdf\" target=\"_blank\" rel=\"noopener\">ICH Q8<\/a> ila\u00e7 geli\u015ftirme i\u00e7in Q9, kalite risk y\u00f6netimi i\u00e7in Q10 ve ila\u00e7 kalite sistemleri i\u00e7in Q10. ICH k\u0131lavuzlar\u0131, \u015firketlerin birden fazla d\u00fczenleyici beklentiyi ayn\u0131 anda kar\u015f\u0131layan s\u00fcre\u00e7ler tasarlamas\u0131na yard\u0131mc\u0131 olur.<\/p><h3><strong><b>4. 21 CFR B\u00f6l\u00fcm 11<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/your-guide-to-21-cfr-part-11-guidelines-for-pharmaceuticals\/\"><span style=\"text-decoration: underline;\">21 CFR B\u00f6l\u00fcm 11<\/span><\/a> G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA) taraf\u0131ndan yay\u0131nlanan bir ABD y\u00f6netmeli\u011fidir. D\u00fczenlemeye tabi faaliyetlerde kullan\u0131lan elektronik kay\u0131tlar ve elektronik imzalar i\u00e7in ge\u00e7erlidir. Bu y\u00f6netmelik, sistemlerin g\u00fcvenli, izlenebilir ve g\u00fcvenilir olmas\u0131n\u0131 \u015fart ko\u015fmaktad\u0131r.<\/p><p>Buna eri\u015fim kontrolleri, denetim izleri, veri yedeklemeleri ve bilgisayarl\u0131 sistemlerin do\u011frulanmas\u0131 dahildir. \u015eirketler, elektronik verilerin do\u011fru oldu\u011funu ve fark edilmeden de\u011fi\u015ftirilemeyece\u011fini kan\u0131tlamak zorundad\u0131r.<\/p><h3><strong><b>5. ISO 13485<\/b><\/strong><\/h3><p>ISO 13485, \u00f6ncelikle t\u0131bbi cihaz sekt\u00f6r\u00fcnde kullan\u0131lan uluslararas\u0131 bir kalite y\u00f6netim standard\u0131d\u0131r. Bununla birlikte, kombinasyon \u00fcr\u00fcnleri veya cihazla ilgili \u00fcretim faaliyetlerinde bulunan ila\u00e7 \u015firketleri i\u00e7in de ge\u00e7erlidir.<\/p><p>Bu standart, yap\u0131land\u0131r\u0131lm\u0131\u015f bir kalite y\u00f6netim sisteminin olu\u015fturulmas\u0131na odaklanmaktad\u0131r. Genel kalite standartlar\u0131ndan farkl\u0131 olarak, ISO 13485, yasal d\u00fczenlemelerdeki beklentilerle yak\u0131ndan uyumludur.<\/p><h3><strong><b>6. \u0130la\u00e7 G\u00fcvenli\u011fi Gereklilikleri<\/b><\/strong><\/h3><p>\u0130la\u00e7 g\u00fcvenli\u011fi izleme, bir \u00fcr\u00fcn\u00fcn piyasaya s\u00fcr\u00fclmesinden sonra ilac\u0131n g\u00fcvenli\u011fini izlemeye odaklan\u0131r. Bu s\u00fcre\u00e7, istenmeyen olaylar\u0131n ve g\u00fcvenlik sinyallerinin toplanmas\u0131n\u0131, incelenmesini ve raporlanmas\u0131n\u0131 i\u00e7erir. \u015eirketler, riskleri erken a\u015famada tespit etmek ve gerekti\u011finde \u00f6nlem almak i\u00e7in gerekli sistemleri kurmal\u0131 ve s\u00fcrd\u00fcrmelidir.<\/p><p>Buna, ciddi istenmeyen olaylar\u0131n belirlenen s\u00fcreler i\u00e7inde d\u00fczenleyici kurumlara bildirilmesi de dahildir. D\u00fczenleyici kurumlar, \u015firketlerin \u00fcr\u00fcn g\u00fcvenli\u011fini aktif olarak izlemesini beklemektedir; sorunlar ortaya \u00e7\u0131kt\u0131ktan sonra tepki vermesini de\u011fil.<\/p><h2><strong><b>Uyum S\u00fcreci Pratikte Nas\u0131l \u0130\u015fliyor?<\/b><\/strong><\/h2><p>\u0130la\u00e7 sekt\u00f6r\u00fcnde mevzuata uygunluk, g\u00fcnl\u00fck i\u015f ak\u0131\u015f\u0131n\u0131n ayr\u0131lmaz bir par\u00e7as\u0131d\u0131r. Bu durum, sistemlerin nas\u0131l tasarland\u0131\u011f\u0131, sorunlar\u0131n nas\u0131l ele al\u0131nd\u0131\u011f\u0131 ve bir denet\u00e7i tesisinize geldi\u011finde tesisin ne kadar haz\u0131r oldu\u011fu gibi hususlarda kendini g\u00f6sterir.<\/p><p>\u0130\u015fte s\u00fcre\u00e7 genellikle \u015fu \u015fekilde i\u015fler.<\/p><h3><strong><b>1. Kalite Y\u00f6netim Sistemleri (KYS)<\/b><\/strong><\/h3><p>Kalite Y\u00f6netim Sistemi, kurulu\u015f genelinde kalitenin nas\u0131l kontrol edildi\u011fini belirler. Bu sistem, belge y\u00f6netimi, de\u011fi\u015fiklik kontrol\u00fc, e\u011fitim, sapma y\u00f6netimi ve y\u00f6netim denetimini kapsar.<\/p><p>Denet\u00e7iler genellikle Kalite Y\u00f6netim Sistemini (QMS) inceleyerek i\u015fe ba\u015flarlar, \u00e7\u00fcnk\u00fc bu sistem kararlar\u0131n nas\u0131l al\u0131nd\u0131\u011f\u0131n\u0131 g\u00f6sterir. Ara\u015ft\u0131rmalar ayr\u0131ca, <a href=\"https:\/\/caliberuniversal.com\/resources\/top-10-fda-483-observations-and-how-to-address-them-effectively\/\" target=\"_blank\" rel=\"noopener\"><u>483 Formu\u2019nun 60% k\u0131sm\u0131<\/u><\/a>\u00a0Bu g\u00f6zlemler, belgelendirmedeki eksikliklerle ba\u011flant\u0131l\u0131d\u0131r.<\/p><h3><strong><b>2. Do\u011frulama ve Yeterlilik Belirleme<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/difference-between-qualification-and-validation-in-pharma\/\"><u>Do\u011frulama ve uygunluk de\u011ferlendirmesi<\/u><\/a>\u00a0Ekipmanlar\u0131n, sistemlerin ve s\u00fcre\u00e7lerin ama\u00e7land\u0131\u011f\u0131 \u015fekilde \u00e7al\u0131\u015ft\u0131\u011f\u0131n\u0131 belgelere dayal\u0131 kan\u0131tlarla ortaya koymak. Buna s\u00fcre\u00e7 do\u011frulama, temizlik do\u011frulama, ekipman yeterlilik de\u011ferlendirmesi ve bilgisayarl\u0131 sistem do\u011frulamas\u0131 dahildir.<\/p><p>D\u00fczenleyici kurumlar, bu kan\u0131tlar\u0131n g\u00fcncel ve izlenebilir olmas\u0131n\u0131 beklemektedir. Nitekim, FDA denetim \u00f6zetleri, proses do\u011frulama ve belgeleme eksikliklerinin ila\u00e7 \u00fcretiminde en s\u0131k belirtilen GMP ihlalleri aras\u0131nda yer ald\u0131\u011f\u0131n\u0131 tutarl\u0131 bir \u015fekilde g\u00f6stermektedir.<\/p><h3><strong><b>3. D\u00fczeltici ve \u00d6nleyici Faaliyetler (CAPA)<\/b><\/strong><\/h3><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/capa-in-the-pharmaceutical-industry\/\"><u>CAPA<\/u><\/a>\u00a0\u015eirketlerin bir sorun ortaya \u00e7\u0131kt\u0131\u011f\u0131nda nas\u0131l tepki verdikleri budur. Bu s\u00fcre\u00e7, bir sorunun temel nedenini belirlemeyi, sorunu gidermeyi ve tekrar ya\u015fanmas\u0131n\u0131 \u00f6nlemeyi i\u00e7erir. D\u00fczenleyici kurumlar CAPA\u2019ya b\u00fcy\u00fck \u00f6nem verir; zira yetersiz ara\u015ft\u0131rmalar, daha derin sorunlar\u0131n varl\u0131\u011f\u0131na i\u015faret eder.<\/p><p>Denetimler s\u0131ras\u0131nda s\u0131k\u00e7a kar\u015f\u0131la\u015f\u0131lan bir sorun, ka\u011f\u0131t \u00fczerinde kapat\u0131lan ancak as\u0131l nedeni ortadan kald\u0131ramayan CAPA\u2019lard\u0131r. Zamanla, etkisiz CAPA sistemleri, sapmalar\u0131n tekrarlanmas\u0131na ve d\u00fczenleyici kurumlar\u0131n g\u00fcveninin sars\u0131lmas\u0131na yol a\u00e7ar.<\/p><h2><strong><b>\u015eirketler Kurallara Uymazsa Ne Olur?<\/b><\/strong><\/h2><p>\u0130la\u00e7 \u015firketleri mevzuata uymad\u0131\u011f\u0131nda, bunun sonu\u00e7lar\u0131 sadece evrak i\u015fleriyle s\u0131n\u0131rl\u0131 kalmaz. Son y\u0131llarda, d\u00fczenleyici kurumlar\u0131n denetimleri keskin bir art\u0131\u015f g\u00f6stermi\u015ftir. Yaln\u0131zca 2023 y\u0131l\u0131nda, FDA <a href=\"https:\/\/pharmanow.live\/editors-choice\/fda-warning-letters-complete-guide\" target=\"_blank\" rel=\"noopener\"><u>1.200'den fazla uyar\u0131 mektubu<\/u><\/a>\u00a0uyulmamas\u0131 durumunda.<\/p><p>Benzer \u015fekilde, mali etkiler de genellikle ciddi boyutlardad\u0131r. Baz\u0131 durumlarda, b\u00fcy\u00fck ila\u00e7 \u015firketleri toplamda y\u00fcz milyonlarca dolarl\u0131k para cezalar\u0131 \u00f6demek zorunda kalm\u0131\u015ft\u0131r.<\/p><p>Sekt\u00f6rdeki uyum ara\u015ft\u0131rmalar\u0131na g\u00f6re, her bir ciddi uyum ihlali ba\u015f\u0131na ortalama maliyetin yakla\u015f\u0131k $15 milyona ula\u015fmas\u0131 bekleniyor. Bu rakam, para cezalar\u0131, d\u00fczeltici \u00f6nlemler ve i\u015f kesintilerini kapsamaktad\u0131r.<\/p><h2><strong><b>Mevzuata Uyum Konusunda En \u0130yi Uygulamalar<\/b><\/strong><\/h2><p>Mevzuata uygunluk, tek ba\u015f\u0131na yap\u0131lan d\u00fczeltmelerle sa\u011flanamaz. Do\u011fru uygulamalar\u0131n g\u00fcnl\u00fck i\u015fleyi\u015fe entegre edilmesi ve t\u00fcm ekipler taraf\u0131ndan tutarl\u0131 bir \u015fekilde uygulanmas\u0131yla sa\u011flan\u0131r. Bu en iyi uygulamalardan baz\u0131lar\u0131 \u015funlard\u0131r:<\/p><h3><strong><b>1. Mevcut Prosed\u00fcrleri S\u00fcrd\u00fcrmek<\/b><\/strong><\/h3><p>Prosed\u00fcrler, i\u015fin y\u0131llar \u00f6nce nas\u0131l tasarland\u0131\u011f\u0131n\u0131 de\u011fil, ger\u00e7ekte nas\u0131l y\u00fcr\u00fct\u00fcld\u00fc\u011f\u00fcn\u00fc yans\u0131tmal\u0131d\u0131r. <a href=\"https:\/\/pharmamachinecn.com\/tr\/sop-in-pharmaceutical-industry\/\"><u>SOP&#039;ler<\/u><\/a>\u00a0Anla\u015f\u0131lmas\u0131 kolay olmal\u0131, d\u00fczenli olarak g\u00f6zden ge\u00e7irilmeli ve de\u011fi\u015fiklikler ya da sapmalar sonras\u0131nda g\u00fcncellenmelidir. G\u00fcncel olmayan prosed\u00fcrler, genellikle uygulama hatalar\u0131na ya da denetimler s\u0131ras\u0131nda eksikliklere yol a\u00e7ar.<\/p><h3><strong><b>2. Etkili E\u011fitim ve Hesap Verebilirlik Yap\u0131s\u0131n\u0131 Olu\u015fturun<\/b><\/strong><\/h3><p>E\u011fitim, sadece onay kay\u0131tlar\u0131n\u0131n \u00f6tesine ge\u00e7melidir. \u00c7al\u0131\u015fanlar, sorumluluklar\u0131n\u0131 ve i\u015flerinin \u00fcr\u00fcn kalitesini ve mevzuata uygunlu\u011fu nas\u0131l etkiledi\u011fini anlamal\u0131d\u0131r. Denetim kurumlar\u0131, denetimler s\u0131ras\u0131nda personelden s\u00fcre\u00e7leri a\u00e7\u0131klamalar\u0131n\u0131 s\u0131k s\u0131k ister ve ortaya \u00e7\u0131kan her t\u00fcrl\u00fc eksiklik, bir ba\u015far\u0131s\u0131zl\u0131k olarak de\u011ferlendirilir.<\/p><h3><strong><b>3. Do\u011frulamay\u0131 bir ya\u015fam d\u00f6ng\u00fcs\u00fc faaliyeti olarak ele al\u0131n<\/b><\/strong><\/h3><p>Do\u011frulama, ilk onaydan sonra sona ermemelidir. Ekipmanlar, s\u00fcre\u00e7ler ve sistemler zamanla de\u011fi\u015fir. De\u011fi\u015fiklikler, e\u011filimler veya ar\u0131zalar\u0131n ard\u0131ndan yap\u0131lan s\u00fcrekli g\u00f6zden ge\u00e7irme, ayn\u0131 bulgular\u0131n tekrarlanmas\u0131n\u0131 \u00f6nlemeye yard\u0131mc\u0131 olur ve do\u011frulama kan\u0131tlar\u0131n\u0131n g\u00fcncel kalmas\u0131n\u0131 sa\u011flar.<\/p><h3><strong><b>4. Temel Nedenleri Gidermek \u0130\u00e7in CAPA\u2019y\u0131 Kullan\u0131n<\/b><\/strong><\/h3><p>Etkili bir CAPA, bir sorunun sadece nas\u0131l h\u0131zl\u0131 bir \u015fekilde \u00e7\u00f6z\u00fclece\u011fine de\u011fil, neden ortaya \u00e7\u0131kt\u0131\u011f\u0131na odaklan\u0131r. K\u00f6k neden analizi, belgelenmi\u015f \u00f6nlemler ve takip kontrolleri hayati \u00f6nem ta\u015f\u0131r. \u00d6te yandan, zay\u0131f CAPA sistemleri genellikle denetimler s\u0131ras\u0131nda ayn\u0131 sorunlar\u0131n tekrar tespit edilmesine yol a\u00e7ar.<\/p><h3><strong><b>5. D\u00fczenli \u0130\u00e7 Denetimler Yap\u0131n<\/b><\/strong><\/h3><p>\u0130\u00e7 denetimler, d\u00fczenleyici kurumlardan \u00f6nce sorunlar\u0131n tespit edilmesine yard\u0131mc\u0131 olur. Mevcut gerekliliklere g\u00f6re yap\u0131lan d\u00fcr\u00fcst bir eksiklik analizi, ekiplerin zay\u0131f noktalar\u0131 erken a\u015famada gidermelerini sa\u011flar. Yaln\u0131zca d\u0131\u015f denetimlere g\u00fcvenen tesisler, sorunlar\u0131 genellikle \u00e7ok ge\u00e7 fark eder.<\/p><h2><strong><b>SSS<\/b><\/strong><\/h2><h3><strong><b>1. \u0130la\u00e7 tedavisine uyum konusunu hangi k\u00fcresel otoriteler denetlemektedir?<\/b><\/strong><\/h3><p>Ba\u015fl\u0131ca denetim, ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA), Avrupa \u0130la\u00e7 Ajans\u0131 (EMA) ve Japonya\u2019n\u0131n PMDA taraf\u0131ndan y\u00fcr\u00fct\u00fclmektedir. Bu kurumlar, s\u0131n\u0131r \u00f6tesi ticaret i\u00e7in k\u00fcresel g\u00fcvenlik ve etkinlik standartlar\u0131n\u0131 uyumlu hale getirmek amac\u0131yla Uluslararas\u0131 Uyum Konseyi (ICH) arac\u0131l\u0131\u011f\u0131yla i\u015fbirli\u011fi yapmaktad\u0131r.<\/p><h3><strong><b>2. Bir \u00fcreticinin kurallara uymamas\u0131n\u0131n sonu\u00e7lar\u0131 nelerdir?<\/b><\/strong><\/h3><p>Sonu\u00e7lar, milyonlarca dolarl\u0131k para cezalar\u0131 ve \u00fcr\u00fcn el koymalar\u0131ndan \u00fcretim lisanslar\u0131n\u0131n tamamen iptal edilmesine kadar uzanmaktad\u0131r. Yasal yapt\u0131r\u0131mlar\u0131n \u00f6tesinde, \u015firketler geri d\u00f6n\u00fc\u015f\u00fc olmayan itibar kayb\u0131yla ve yat\u0131r\u0131mc\u0131 g\u00fcveninin yitirilmesiyle kar\u015f\u0131 kar\u015f\u0131ya kalmaktad\u0131r; bu durum, gelecekteki ila\u00e7 geli\u015ftirme projelerinin durmas\u0131na neden olabilir.<\/p><h3><strong><b>3. GxP ne anlama gelir ve neden ila\u00e7 sekt\u00f6r\u00fcnde evrensel bir terimdir?<\/b><\/strong><\/h3><p><strong><b>GxP<\/b><\/strong>\u00a0\u201c\u0130yi Uygulama\u201d k\u0131lavuzlar\u0131 i\u00e7in kullan\u0131lan genel bir terimdir. \u201cx\u201d harfi, ilgili alana g\u00f6re de\u011fi\u015fen bir de\u011fi\u015fkendir:<\/p><ul><li><b><\/b><strong><b>GMP: <\/b><\/strong>\u0130yi \u00dcretim Uygulamalar\u0131 (\u00fcretime odaklan\u0131r).<\/li><li><b><\/b><strong><b>GCP: <\/b><\/strong>\u0130yi Klinik Uygulamalar (klinik ara\u015ft\u0131rmalara odaklan\u0131r).<\/li><li><b><\/b><strong><b>GLP: <\/b><\/strong>\u0130yi Laboratuvar Uygulamalar\u0131 (laboratuvar testlerine odaklan\u0131r).<\/li><li><b><\/b><strong><b>GSY\u0130H:<\/b><\/strong>\u0130yi Da\u011f\u0131t\u0131m Uygulamalar\u0131 (depolama ve nakliyeye odaklan\u0131r).<\/li><\/ul><p>Bu \u201cUygulamalara\u201d uyulmas\u0131, \u00fcr\u00fcn\u00fcn kullan\u0131m amac\u0131na uygun kalite standartlar\u0131 do\u011frultusunda tutarl\u0131 bir \u00fcretim ve kontrol\u00fcn sa\u011flanmas\u0131na yard\u0131mc\u0131 olur.<\/p><h3><strong><b>4. Farmakovijilans (PV) uyumu nedir ve neden zorunludur?<\/b><\/strong><\/h3><p>\u0130la\u00e7 g\u00fcvenli\u011fi uyumu, ila\u00e7 \u015firketlerinin, ila\u00e7lar\u0131n\u0131n piyasaya s\u00fcr\u00fclmesinden sonra bu ila\u00e7larla ili\u015fkili olas\u0131 yan etkileri izlemesi, tespit etmesi ve bildirmesi y\u00f6n\u00fcndeki yasal y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc ifade eder. Klinik ara\u015ft\u0131rmalar ilk a\u015famadaki g\u00fcvenlik verilerini sa\u011flasa da, farkl\u0131 sa\u011fl\u0131k ge\u00e7mi\u015flerine sahip milyonlarca ki\u015fi taraf\u0131ndan bir ilac\u0131n kullan\u0131lmas\u0131 durumunda ortaya \u00e7\u0131kabilecek her t\u00fcrl\u00fc nadir reaksiyonu tam olarak tespit edemez.<\/p><p>FDA ve EMA gibi d\u00fczenleyici kurumlar, bir ilac\u0131n risk-fayda oran\u0131n\u0131n t\u00fcm ya\u015fam d\u00f6ng\u00fcs\u00fc boyunca uygun seviyede kalmas\u0131n\u0131 sa\u011flamak amac\u0131yla bu s\u00fcreci zorunlu k\u0131lmaktad\u0131r.<\/p><h2><strong><b>Uyum, Do\u011fru Sistemlerle Ba\u015flar<\/b><\/strong><\/h2><p>\u0130la\u00e7 sekt\u00f6r\u00fcnde mevzuata uygunluk, kulland\u0131\u011f\u0131n\u0131z ekipmanlara ve birlikte \u00e7al\u0131\u015fmay\u0131 tercih etti\u011finiz \u015firkete de ba\u011fl\u0131d\u0131r. Tasar\u0131m\u0131 yetersiz, temizlenmesi zor veya performans\u0131 tutars\u0131z makineler, mevzuata uygunluk riskleri yarat\u0131r.<\/p><p>\u0130\u015fte bu y\u00fczden Finetech\u2019ten ba\u015fka bir yere bakman\u0131za gerek yok.<\/p><p>\u00dcreticilere GMP standartlar\u0131na uygun ekipmanlar ve uzun vadeli teknik destek sunuyoruz. On y\u0131llara dayanan deneyimimiz, \u015firket i\u00e7i kalite kontrol sistemimiz ve 100 \u00fclkede ger\u00e7ekle\u015ftirdi\u011fimiz kurulum hizmetlerimizle, \u00fcreticilerin mevzuata uygunluk risklerini azaltmalar\u0131na yard\u0131mc\u0131 oluyoruz.<\/p><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/contact-us\/\"><em><u><i>Bug\u00fcn Finetech ile ileti\u015fime ge\u00e7in<\/i><\/u><\/em><\/a><em><i>\u00a0ya da bizi \u015fu numaradan arayabilirsiniz: <\/i><\/em><a href=\"tel:+86%2015382537883\"><em><u><i>+86-15382537883<\/i><\/u><\/em><\/a><em><i>\u00a0H\u0131zl\u0131 bir dan\u0131\u015fma i\u00e7in!<\/i><\/em><\/p><h2><strong>Referanslar:<\/strong><\/h2><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/what-are-the-difference-with-gmp-gdp-fda-dmf-and-cep\/\"><span style=\"text-decoration: underline;\"><em><strong>GMP, GDP, FDA, DMF ve CEP Nedir: Temel Farklar\u0131 Anlamak<\/strong><\/em><\/span><\/a>.<\/p><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/key-global-certifications-for-pharmaceutical-industry-manufacturers\/\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 Sekt\u00f6r\u00fc \u00dcreticileri \u0130\u00e7in \u00d6nemli Uluslararas\u0131 Sertifikalar.<\/strong><\/em><\/span><\/a><\/p><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/capa-in-the-pharmaceutical-industry\/\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 End\u00fcstrisinde CAPA.<\/strong><\/em><\/span><\/a><\/p><p><a href=\"https:\/\/pharmamachinecn.com\/tr\/how-many-iso-standards-are-there-in-the-pharmaceutical-industry\/\"><span style=\"text-decoration: underline;\"><em><strong>\u0130la\u00e7 Sekt\u00f6r\u00fcnde Ka\u00e7 Adet ISO Standard\u0131 Vard\u0131r?<\/strong><\/em><\/span><\/a><\/p><h2><b>Telif Hakk\u0131 Uyar\u0131s\u0131:<\/b><\/h2><p>Finetech Group'un \u00f6nceden a\u00e7\u0131k yaz\u0131l\u0131 onay\u0131 olmadan bu web sitesindeki herhangi bir i\u00e7eri\u011fi \u00e7o\u011faltamaz, de\u011fi\u015ftiremez, yay\u0131nlayamaz, g\u00f6r\u00fcnt\u00fcleyemez, iletemez veya herhangi bir \u015fekilde istismar edemezsiniz veya bu t\u00fcr i\u00e7eri\u011fi herhangi bir veritaban\u0131 olu\u015fturmak i\u00e7in kullanamazs\u0131n\u0131z. \u0130\u00e7eri\u011fi kullanma izni i\u00e7in l\u00fctfen ileti\u015fime ge\u00e7in: <a href=\"mailto:info@pharmamachinecn.com\"><span style=\"text-decoration: underline;\">info@pharmamachinecn.com<\/span><\/a><\/p><h2><b>Yasal Uyar\u0131:<\/b><\/h2><p>Bu makalede yer alan bilgiler yaln\u0131zca genel bilgilendirme ama\u00e7l\u0131d\u0131r. \u015eirket, herhangi bir bilginin do\u011frulu\u011funu, g\u00fcncelli\u011fini veya eksiksizli\u011fini garanti etmez ve \u015eirket, bu makalenin i\u00e7eri\u011findeki hatalar veya eksiklikler i\u00e7in hi\u00e7bir sorumluluk kabul etmez.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Regulatory compliance in the pharmaceutical industry is about following the rules that govern how medicines are developed, manufactured, tested, stored, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[61],"tags":[],"class_list":["post-17360","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-technology"],"acf":[],"_links":{"self":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/17360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/comments?post=17360"}],"version-history":[{"count":0,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/posts\/17360\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media\/17434"}],"wp:attachment":[{"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/media?parent=17360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/categories?post=17360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmamachinecn.com\/tr\/wp-json\/wp\/v2\/tags?post=17360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}